ABIVAX: cashflow_financing
| Value | {"amount": 32211000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | ABIVAX |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:24:23.944687+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/4e78763f-5fa5-4262-8834-131dcdbeb081
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500D8TMNB184OJU95:2024-12-31Retrieved: 2026-08-23T23:24:23.944687+02:00
Raw response sha256:
93c3ec69aab1a72ebb2f46a3c9996848…Cite as: FACTANKER, https://factanker.com/fact/4e78763f-5fa5-4262-8834-131dcdbeb081
History
- no predecessors — first report